Latest period
$26.48B
YoY change
+16.0%
5Y CAGR
+17.3%
Peak year (2025)
$26.14B
Latest annual
$26.14B
Total Assets history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
Latest: $26.14B
Total Assets growth chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
Latest: +16.0%
Total Assets history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
| 2025 | $26.14B | +16.0% | +$3.61B | ||
| 2024 | $22.53B | -0.9% | −$197.00M | ||
| 2023 | $22.73B | +25.2% | +$4.58B | ||
| 2022 | $18.15B | +35.1% | +$4.72B | ||
| 2021 | $13.43B | +14.3% | +$1.68B | ||
| 2020 | $11.75B | +41.3% | +$3.43B | ||
| 2019 | $8.32B | +33.2% | +$2.07B | ||
| 2018 | $6.25B | +76.1% | +$2.70B | ||
| 2017 | $3.55B | +22.5% | +$652.23M | ||
| 2016 | $2.89B | +15.9% | +$396.74M | ||
| 2015 | $2.50B | +6.9% | +$160.74M | ||
| 2014 | $2.34B | +0.7% | +$17.27M | ||
| 2013 | $2.32B | -16.0% | −$440.25M | ||
| 2012 | $2.76B | +25.2% | +$555.01M | ||
| 2011 | $2.20B | +27.8% | +$478.83M | ||
| 2010 | $1.73B | -11.8% | −$230.05M | ||
| 2009 | $1.96B | +99.4% | +$975.02M | ||
| 2008 | $980.48M | +63.0% | +$379.00M | ||
| 2007 | $601.48M | -34.7% | −$320.10M | ||
| 2006 | $921.58M | +67.9% | +$372.58M | ||
| 2005 | $549.00M | +0.6% | +$3.54M | ||
| 2004 | $545.45M | -24.7% | −$178.96M | ||
| 2003 | $724.41M | -11.2% | −$91.31M | ||
| 2002 | $815.72M | -11.8% | −$109.41M | ||
| 2001 | $925.13M | +19.7% | +$152.25M | ||
| 2000 | $772.88M | +232.6% | +$540.48M | ||
| 1999 | $232.40M | -12.7% | −$33.90M | ||
| 1998 | $266.30M | -9.9% | −$29.30M | ||
| 1997 | $295.60M | +106.0% | +$152.10M | ||
| 1996 | $143.50M | +44.9% | +$44.50M | ||
| 1995 | $99.00M | -14.8% | −$17.20M | ||
| 1994 | $116.20M | +90.5% | +$55.20M | ||
| 1993 | $61.00M | +19.6% | +$10.00M | ||
| 1992 | $51.00M | -10.7% | −$6.10M | ||
| 1991 | $57.10M | +520.7% | +$47.90M | ||
| 1990 | $9.20M | — | — |
- 2025$26.14B+16.0%
- 2024$22.53B-0.9%
- 2023$22.73B+25.2%
- 2022$18.15B+35.1%
- 2021$13.43B+14.3%
- 2020$11.75B+41.3%
- 2019$8.32B+33.2%
- 2018$6.25B+76.1%
- 2017$3.55B+22.5%
- 2016$2.89B+15.9%
- 2015$2.50B+6.9%
- 2014$2.34B+0.7%
- 2013$2.32B-16.0%
- 2012$2.76B+25.2%
- 2011$2.20B+27.8%
- 2010$1.73B-11.8%
- 2009$1.96B+99.4%
- 2008$980.48M+63.0%
- 2007$601.48M-34.7%
- 2006$921.58M+67.9%
- 2005$549.00M+0.6%
- 2004$545.45M-24.7%
- 2003$724.41M-11.2%
- 2002$815.72M-11.8%
- 2001$925.13M+19.7%
- 2000$772.88M+232.6%
- 1999$232.40M-12.7%
- 1998$266.30M-9.9%
- 1997$295.60M+106.0%
- 1996$143.50M+44.9%
- 1995$99.00M-14.8%
- 1994$116.20M+90.5%
- 1993$61.00M+19.6%
- 1992$51.00M-10.7%
- 1991$57.10M+520.7%
- 1990$9.20M—
Total Assets values are taken from Vertex Pharmaceuticals's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported total assets is $26.48B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Vertex Pharmaceuticals (VRTX) total assets is $26.14B – grew 16.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Vertex Pharmaceuticals total assets compounded at +17.3% per year, with mixed annual results across the window.
The record annual total assets stands at $26.14B, reached in 2025; the historical low of $9.20M was recorded in 1990.
Vertex Pharmaceuticals Total Assets by Year
Vertex Pharmaceuticals Total Assets 2025: $26.14B
In 2025, Vertex Pharmaceuticals reported total assets of $26.14B, grew 16.0% from 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals Total Assets 2024: $22.53B
Vertex Pharmaceuticals total assets in 2024 was $22.53B, edged down 0.9% below 2023.
Vertex Pharmaceuticals Total Assets 2023: $22.73B
2023's total assets for Vertex Pharmaceuticals came in at $22.73B, grew 25.2% from 2022.
Vertex Pharmaceuticals Total Assets 2022: $18.15B
Vertex Pharmaceuticals posted total assets of $18.15B in 2022, surged 35.1% from 2021.
Vertex Pharmaceuticals Total Assets 2021: $13.43B
Vertex Pharmaceuticals total assets in 2021 was $13.43B.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers by Total Assets
Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Vertex Pharmaceuticals (VRTX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation